InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in InflaRx N.V. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +5 vs. Q2 2023
- Shares held
- 19.0M
- +478.2K (+2.6%) vs. Q2 2023
- Total value
- $56.8M
- −$26.0M (−31.4%) vs. Q2 2023
- New holders
- 10
- 14 more added
- Sold out
- 5
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IFRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $211.6M |
| Q1 2026 | 35 | $16.9M |
| Q4 2025 | 34 | $19.6M |
| Q3 2025 | 27 | $24.9M |
| Q2 2025 | 27 | $13.3M |
| Q1 2025 | 31 | $17.9M |
| Q4 2024 | 30 | $32.1M |
| Q3 2024 | 27 | $19.7M |
| Q2 2024 | 33 | $23.0M |
| Q1 2024 | 37 | $21.3M |
| Q4 2023 | 39 | $27.8M |
| Q3 2023 | 42 | $56.8M |
| Q2 2023 | 37 | $82.7M |
| Q1 2023 | 25 | $7.08M |
| Q4 2022 | 33 | $11.6M |
| Q3 2022 | 30 | $10.5M |
| Q2 2022 | 27 | $7.63M |
| Q1 2022 | 32 | $12.0M |
| Q4 2021 | 38 | $44.1M |
| Q3 2021 | 35 | $23.0M |
| Q2 2021 | 37 | $33.1M |
| Q1 2021 | 42 | $56.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding InflaRx N.V.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harbour Investments, Inc. | 100 | $298 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 463 | $1.38K | 0.00% | +463 | New |
| Citigroup Inc | 1,301 | $3.88K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1,400 | $4.17K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 2,800 | $8.34K | 0.00% | +2,800 | New |
| Group One Trading, L.P. | 3,831 | $11.4K | 0.00% | +3,831 | New |
| Steward Partners Investment Advisory, LLC | 4,800 | $14.3K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 7,482 | $22.0K | 0.00% | −17,450−70.0% | Reduced |
| Tower Research Capital LLC (TRC) | 8,022 | $23.9K | 0.00% | +6,143+326.9% | Added |
| Two Sigma Investments, LP | 12,425 | $37.0K | 0.00% | +12,425 | New |
| Marshall Wace, LLP | 12,501 | $37.3K | 0.00% | +12,501 | New |
| Citadel Advisors LLC | 12,868 | $38.3K | 0.00% | +12,868 | New |
| XTX Topco Ltd | 14,588 | $43.5K | 0.01% | +14,588 | New |
| Pacifica Partners Inc. | 20,585 | $52.1K | 0.03% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 21,998 | $65.6K | 0.00% | +702+3.3% | Added |
| Virtu Financial LLC | 23,138 | $69.0K | 0.01% | +23,138 | New |
| JPMorgan Chase & Co | 33,300 | $99.2K | 0.00% | −18,318−35.5% | Reduced |
| Geode Capital Management, LLC | 36,236 | $108.0K | 0.00% | +4,942+15.8% | Added |
| Susquehanna International Group, LLP | 37,091 | $110.5K | 0.00% | −141,153−79.2% | Reduced |
| Franklin Street Advisors Inc | 50,100 | $149.0K | 0.01% | 00.0% | Unchanged |
| Birchview Capital, LP | 50,000 | $149.0K | 0.13% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 55,192 | $164.5K | 0.01% | +9,951+22.0% | Added |
| Commonwealth Equity Services, LLC | 90,000 | $268.0K | 0.00% | 00.0% | Unchanged |
| Alps Advisors Inc | 83,279 | $307.0K | 0.00% | +43,501+109.4% | Added |
| J. Goldman & Co LP | 108,001 | $321.8K | 0.02% | −204,141−65.4% | Reduced |
| Woodline Partners LP | 130,293 | $388.3K | 0.00% | −362,303−73.5% | Reduced |
| Millennium Management LLC | 132,658 | $395.3K | 0.00% | −238,453−64.3% | Reduced |
| Boothbay Fund Management, LLC | 141,652 | $422.1K | 0.01% | +141,652 | New |
| Raymond James & Associates | 162,406 | $484.0K | 0.00% | +25,350+18.5% | Added |
| Invesco Ltd. | 163,950 | $488.6K | 0.00% | +7,343+4.7% | Added |
| Velan Capital Investment Management LP | 200,000 | $596.0K | 0.49% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 268,915 | $801.4K | 0.00% | +84,178+45.6% | Added |
| Affinity Asset Advisors, LLC | 325,097 | $968.8K | 0.32% | +84,897+35.3% | Added |
| Schonfeld Strategic Advisors LLC | 371,222 | $1.11M | 0.01% | +2,229+0.6% | Added |
| UBS Oconnor LLC | 390,000 | $1.16M | 0.02% | +85,000+27.9% | Added |
| Morgan Stanley | 634,120 | $1.89M | 0.00% | +4,200+0.7% | Added |
| Ikarian Capital, LLC | 688,604 | $2.05M | 0.76% | +688,604 | New |
| Eversept Partners, LP | 1,737,544 | $5.18M | 0.57% | −177,569−9.3% | Reduced |
| Point72 Asset Management, L.P. | 2,081,293 | $6.20M | 0.02% | +168,535+8.8% | Added |
| 683 Capital Management, LLC | 2,350,000 | $7.00M | 0.71% | +350,000+17.5% | Added |
| Tang Capital Management LLC | 2,824,353 | $8.42M | 1.19% | −75,647−2.6% | Reduced |
| Suvretta Capital Management, LLC | 5,733,910 | $17.1M | 0.92% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −34,891−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −22,900−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −7,945−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −893−100.0% | Sold out |